 |
|
Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants
A Randomized Controlled Trial
Richard L. Kravitz, MD, MSPH;
Ronald M. Epstein, MD;
Mitchell D. Feldman, MD, MPhil;
Carol E. Franz, PhD;
Rahman Azari, PhD;
Michael S. Wilkes, MD, PhD;
Ladson Hinton, MD;
Peter Franks, MD
JAMA. 2005;293:1995-2002.
Context Direct-to-consumer (DTC) advertising of prescription drugs in the United States is both ubiquitous and controversial. Critics charge that it leads to overprescribing, while proponents counter that it helps avert underuse of effective treatments, especially for conditions that are poorly recognized or stigmatized.
Objective To ascertain the effects of patients’ DTC-related requests on physicians’ initial treatment decisions in patients with depressive symptoms.
Design Randomized trial using standardized patients (SPs). Six SP roles were created by crossing 2 conditions (major depression or adjustment disorder with depressed mood) with 3 request types (brand-specific, general, or none).
Setting Offices of primary care physicians in Sacramento, Calif; San Francisco, Calif; and Rochester, NY, between May 2003 and May 2004.
Participants One hundred fifty-two family physicians and general internists recruited from solo and group practices and health maintenance organizations; cooperation rates ranged from 53% to 61%.
Interventions The SPs were randomly assigned to make 298 unannounced visits, with assignments constrained so physicians saw 1 SP with major depression and 1 with adjustment disorder. The SPs made a brand-specific drug request, a general drug request, or no request (control condition) in approximately one third of visits.
Main Outcome Measures Data on prescribing, mental health referral, and primary care follow-up obtained from SP written reports, visit audiorecordings, chart review, and analysis of written prescriptions and drug samples. The effects of request type on prescribing were evaluated using contingency tables and confirmed in generalized linear mixed models that accounted for clustering and adjusted for site, physician, and visit characteristics.
Results Standardized patient role fidelity was excellent, and the suspicion rate that physicians had seen an SP was 13%. In major depression, rates of antidepressant prescribing were 53%, 76%, and 31% for SPs making brand-specific, general, and no requests, respectively (P<.001). In adjustment disorder, antidepressant prescribing rates were 55%, 39%, and 10%, respectively (P<.001). The results were confirmed in multivariate models. Minimally acceptable initial care (any combination of an antidepressant, mental health referral, or follow-up within 2 weeks) was offered to 98% of SPs in the major depression role making a general request, 90% of those making a brand-specific request, and 56% of those making no request (P<.001).
Conclusions Patients’ requests have a profound effect on physician prescribing in major depression and adjustment disorder. Direct-to-consumer advertising may have competing effects on quality, potentially both averting underuse and promoting overuse.
Author Affiliations: Center for Health Services Research in Primary Care (Drs Kravitz, Franz, Azari, Wilkes, Hinton, and Franks) and Departments of Internal Medicine (Drs Kravitz and Wilkes), Statistics (Dr Azari), Psychiatry (Dr Hinton), and Family and Community Medicine (Dr Franks), University of California, Davis, Sacramento; Departments of Family Medicine and Psychiatry and Center to Improve Communication in Health Care, University of Rochester School of Medicine and Dentistry, Rochester, NY (Dr Epstein); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (Dr Feldman).
RELATED LETTERS
Direct-to-Consumer Advertising and Physician Prescribing
Franklin G. Miller and David Wendler
JAMA. 2005;294(6):678.
EXTRACT
| FULL TEXT
Direct-to-Consumer Advertising and Physician Prescribing—Reply
Richard L. Kravitz, Peter Franks, Ronald M. Epstein, Mitchell D. Feldman, and Carol E. Franz
JAMA. 2005;294(6):678-679.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
Matthew F. Hollon
JAMA. 2005;293(16):2030-2033.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Aiding Medical Decision Making: A Communication Perspective
Street
Med Decis Making 2007;27:550-553.
Understanding Mental Health Treatment in Persons Without Mental Diagnoses: Results From the National Comorbidity Survey Replication
Druss et al.
Arch Gen Psychiatry 2007;64:1196-1203.
ABSTRACT
| FULL TEXT
Let's Not Talk About It: Suicide Inquiry in Primary Care
Feldman et al.
Ann Fam Med 2007;5:412-418.
ABSTRACT
| FULL TEXT
A Decade of Direct-to-Consumer Advertising of Prescription Drugs
Donohue et al.
NEJM 2007;357:673-681.
ABSTRACT
| FULL TEXT
The High Cost of Free Lunch
Wall and Brown
Obstet Gynecol 2007;110:169-173.
ABSTRACT
| FULL TEXT
Physician Self-disclosure in Primary Care Visits: Enough About You, What About Me?
McDaniel et al.
Arch Intern Med 2007;167:1321-1326.
ABSTRACT
| FULL TEXT
Behind Closed Doors: Management of Patient Expectations in Primary Care Practices
Keitz et al.
Arch Intern Med 2007;167:445-452.
ABSTRACT
| FULL TEXT
Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising
Jagsi
JCO 2007;25:902-905.
FULL TEXT
Time to Ban Direct-to-Consumer Prescription Drug Marketing
Stange
Ann Fam Med 2007;5:101-104.
FULL TEXT
Ratings of Physician Communication by Real and Standardized Patients
Fiscella et al.
Ann Fam Med 2007;5:151-158.
ABSTRACT
| FULL TEXT
Assessment in Medical Education
Epstein
NEJM 2007;356:387-396.
FULL TEXT
Antidepressant Utilization in British Columbia From 1996 to 2004: Increasing Prevalence but Not Incidence
Raymond et al.
Psychiatr. Serv. 2007;58:79-84.
ABSTRACT
| FULL TEXT
In This Issue: Doctor-Patient and Drug Company-Patient Communication
Stange
Ann Fam Med 2007;5:2-4.
FULL TEXT
Exploring and Validating Patient Concerns: Relation to Prescribing for Depression
Epstein et al.
Ann Fam Med 2007;5:21-28.
ABSTRACT
| FULL TEXT
Assessment of Clinical Skills Using Simulator Technologies
Srinivasan et al.
Acad. Psychiatry 2006;30:505-515.
ABSTRACT
| FULL TEXT
Prescription of tamoxifen for breast cancer prevention by primary care physicians.
Armstrong et al.
Arch Intern Med 2006;166:2260-2265.
ABSTRACT
| FULL TEXT
The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and {omega}3 Fatty Acid Prescribing Behaviors
Oh et al.
J Am Board Fam Med 2006;19:459-467.
ABSTRACT
| FULL TEXT
Changing Profiles of Service Sectors Used for Mental Health Care in the United States
Wang et al.
Am. J. Psychiatry 2006;163:1187-1198.
ABSTRACT
| FULL TEXT
A Framework to Improve the Quality of Treatment for Depression in Primary Care
Croghan et al.
Psychiatr. Serv. 2006;57:623-630.
ABSTRACT
| FULL TEXT
Prices, profits, and innovation: examining criticisms of new psychotropic drugs' value.
Huskamp
Health Aff (Millwood) 2006;25:635-646.
ABSTRACT
| FULL TEXT
"Your Life is Waiting!": Symbolic Meanings in Direct-to-Consumer Antidepressant Advertising
Grow et al.
Journal of Communication Inquiry 2006;30:163-188.
ABSTRACT
Reconsidering medication appropriateness for patients late in life.
Holmes et al.
Arch Intern Med 2006;166:605-609.
FULL TEXT
Physicians' responses to patients' medically unexplained symptoms.
Epstein et al.
Psychosom. Med. 2006;68:269-276.
ABSTRACT
| FULL TEXT
A 54-Year-Old Woman With Constipation-Predominant Irritable Bowel Syndrome
Lembo
JAMA 2006;295:925-933.
FULL TEXT
Direct-to-Consumer Advertising in Oncology.
Abel et al.
The Oncologist 2006;11:217-226.
ABSTRACT
| FULL TEXT
Quality of Preventive Care for Diabetes: Effects of Visit Frequency and Competing Demands
Fenton et al.
Ann Fam Med 2006;4:32-39.
ABSTRACT
| FULL TEXT
How Hospitals Confront New Technology
Coye and Kell
Health Aff (Millwood) 2006;25:163-173.
ABSTRACT
| FULL TEXT
Medicine by media: Did a critical television documentary affect the prescribing of cyproterone- estradiol (Diane-35)?
Mintzes et al.
CMAJ 2005;173:1313-1315.
FULL TEXT
Direct-to-Consumer Advertising of COX-2 Inhibitors: Effect on Appropriateness of Prescribing
Spence et al.
Med Care Res Rev 2005;62:544-559.
ABSTRACT
Patient-Centered Communication and Diagnostic Testing
Epstein et al.
Ann Fam Med 2005;3:415-421.
ABSTRACT
| FULL TEXT
Direct-to-Consumer Advertising and Physician Prescribing
Miller and Wendler
JAMA 2005;294:678-678.
FULL TEXT
PEDIATRICS & ADOLESCENT MEDICINE
Arch. Dis. Child. 2005;90:873-874.
FULL TEXT
Direct-to-Consumer Advertising of Antidepressants and Prescribing Behavior
JWatch Psychiatry 2005;2005:2-2.
FULL TEXT
Influence of Direct-to-Consumer Advertising on Antidepressant Prescriptions
JWatch General 2005;2005:1-1.
FULL TEXT
Consumer advertising influences doctors' prescribing, study finds
Gottlieb
BMJ 2005;330:983-983.
FULL TEXT
Direct-to-Consumer Advertising: A Haphazard Approach to Health Promotion
Hollon
JAMA 2005;293:2030-2033.
FULL TEXT
|
